146 related articles for article (PubMed ID: 19434815)
1. Treatment with levamisole and colchicine can result in a significant reduction of IL-6, IL-8 or TNF-alpha level in patients with mucocutaneous type of Behcet's disease.
Sun A; Wang YP; Chia JS; Liu BY; Chiang CP
J Oral Pathol Med; 2009 May; 38(5):401-5. PubMed ID: 19434815
[TBL] [Abstract][Full Text] [Related]
2. Levamisole can modulate the serum tumor necrosis factor-alpha level in patients with recurrent aphthous ulcerations.
Sun A; Wang JT; Chia JS; Chiang CP
J Oral Pathol Med; 2006 Feb; 35(2):111-6. PubMed ID: 16430742
[TBL] [Abstract][Full Text] [Related]
3. Levamisole and Chinese medicinal herbs can modulate the serum interleukin-6 level in patients with recurrent aphthous ulcerations.
Sun A; Chia JS; Chang YF; Chiang CP
J Oral Pathol Med; 2003 Apr; 32(4):206-14. PubMed ID: 12653859
[TBL] [Abstract][Full Text] [Related]
4. Serum interleukin-6 level is a useful marker in evaluating therapeutic effects of levamisole and Chinese medicinal herbs on patients with oral lichen planus.
Sun A; Chia JS; Chang YF; Chiang CP
J Oral Pathol Med; 2002 Apr; 31(4):196-203. PubMed ID: 12076322
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease.
Evereklioglu C; Er H; Türköz Y; Cekmen M
Mediators Inflamm; 2002 Apr; 11(2):87-93. PubMed ID: 12061429
[TBL] [Abstract][Full Text] [Related]
6. Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of recurrent aphthous ulcerations.
Sun A; Chang YF; Chia JS; Chiang CP
J Oral Pathol Med; 2004 Mar; 33(3):133-9. PubMed ID: 15128054
[TBL] [Abstract][Full Text] [Related]
7. Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of oral lichen planus.
Sun A; Wang JT; Chia JS; Chiang CP
Br J Dermatol; 2005 Jun; 152(6):1187-92. PubMed ID: 15948980
[TBL] [Abstract][Full Text] [Related]
8. Levamisole can reduce the high serum tumour necrosis factor-alpha level to a normal level in patients with erosive oral lichen planus.
Sun A; Chia JS; Wang JT; Chiang CP
Clin Exp Dermatol; 2007 May; 32(3):308-10. PubMed ID: 17397355
[TBL] [Abstract][Full Text] [Related]
9. Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet's disease.
Akdeniz N; Esrefoglu M; Keleş MS; Karakuzu A; Atasoy M
Ann Acad Med Singap; 2004 Sep; 33(5):596-9. PubMed ID: 15531955
[TBL] [Abstract][Full Text] [Related]
10. Effects of interferon-alpha treatment on serum IL-6, IL-8, TNF-alpha and soluble TNF-alpha receptors in Behçet's disease.
Direskeneli H; Fresko I; Hamuryudan V
Scand J Rheumatol; 2005; 34(1):75-6. PubMed ID: 15903033
[No Abstract] [Full Text] [Related]
11. [The treatment of Behçet's disease].
Hamza M; Ben Ayed H
Tunis Med; 1980; 58(1-2):394-6. PubMed ID: 7210186
[No Abstract] [Full Text] [Related]
12. Adamantiades-Behçet's disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells.
Zouboulis CC; Katsantonis J; Ketteler R; Treudler R; Kaklamani E; Hornemann S; Kaklamanis P; Orfanos CE
Arch Dermatol Res; 2000 Jun; 292(6):279-84. PubMed ID: 10929768
[TBL] [Abstract][Full Text] [Related]
13. Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease.
Oztas MO; Onder M; Gurer MA; Bukan N; Sancak B
Clin Exp Dermatol; 2005 Jan; 30(1):61-3. PubMed ID: 15663506
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome.
Cekmen M; Evereklioglu C; Er H; Inalöz HS; Doganay S; Türköz Y; Ozerol IH
Int J Dermatol; 2003 Nov; 42(11):870-5. PubMed ID: 14636202
[TBL] [Abstract][Full Text] [Related]
15. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.
Doganay S; Evereklioglu C; Er H; Türköz Y; Sevinç A; Mehmet N; Savli H
Eye (Lond); 2002 Mar; 16(2):163-70. PubMed ID: 11988817
[TBL] [Abstract][Full Text] [Related]
16. Effects of interferon-alpha2a treatment on serum levels of tumor necrosis factor-alpha, tumor necrosis factor-alpha2 receptor, interleukin-2, interleukin-2 receptor, and E-selectin in Behçet's disease.
Kosar A; Haznedaroglu S; Karaaslan Y; Büyükasik Y; Haznedaroglu IC; Ozath D; Sayinalp N; Ozcebe O; Kirazli S; Dündar S
Rheumatol Int; 1999; 19(1-2):11-4. PubMed ID: 10651074
[TBL] [Abstract][Full Text] [Related]
17. [Effect of tripterygium glycosides on serum interleukin-1beta, interleukin-2, tumor necrosis factor alpha, and interferon-gamma levels in patients with Behcet's disease].
Song Q; Lu JZ; Li J
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jun; 30(6):598-600. PubMed ID: 20815274
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of apremilast and its impact on serum cytokine levels in patients with Behçet's disease.
Wakiya R; Ushio Y; Ueeda K; Kameda T; Shimada H; Nakashima S; Kato M; Miyagi T; Sugihara K; Mizusaki M; Mino R; Kadowaki N; Dobashi H
Dermatol Ther; 2022 Aug; 35(8):e15616. PubMed ID: 35668044
[TBL] [Abstract][Full Text] [Related]
19. Cytokines in Behçet's disease.
Sayinalp N; Ozcebe OI; Ozdemir O; Haznedaroğlu IC; Dündar S; Kirazli S
J Rheumatol; 1996 Feb; 23(2):321-2. PubMed ID: 8882039
[TBL] [Abstract][Full Text] [Related]
20. [Selected cytokines (Il-6, Il-8, Il-10, MCP-1, TNF-alpha) in children and adolescents with atherosclerosis risk factors: obesity, hypertension, diabetes].
Głowińska B; Urban M
Wiad Lek; 2003; 56(3-4):109-16. PubMed ID: 12923954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
